These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6346623)

  • 1. [Plasminogen activators and their physiological role].
    Andreenko GV
    Ukr Biokhim Zh (1978); 1983; 55(3):329-43. PubMed ID: 6346623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
    Páramo JA; Collen D
    Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
    [No Abstract]   [Full Text] [Related]  

  • 3. A sensitive and specific assay for plasminogen activators.
    Smith DS; Harmon J; Owen WG
    Thromb Res; 1985 Feb; 37(4):533-41. PubMed ID: 4039078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activation and regulation of pericellular proteolysis.
    Saksela O
    Biochim Biophys Acta; 1985 Nov; 823(1):35-65. PubMed ID: 2413894
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasminogen activators in tumor tissue].
    Tomasiuk R; Mirowski M; Wierzbicki R
    Pol Arch Med Wewn; 1989 Jun; 81(6):355-63. PubMed ID: 2517455
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enzymatic determination of plasminogen activators].
    Fischer BE
    Z Med Lab Diagn; 1988; 29(6):327-32. PubMed ID: 2973186
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
    Arimura H; Kasai S; Nishida M; Suyama T
    Rinsho Byori; 1989 Apr; Spec No 81():107-17. PubMed ID: 2502639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent].
    Collen D
    Verh K Acad Geneeskd Belg; 1982; 44(5-6):295-305. PubMed ID: 6223460
    [No Abstract]   [Full Text] [Related]  

  • 11. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methods of derivation and physico-chemical properties of plasminogen activators].
    Makogonenko EM
    Ukr Biokhim Zh (1978); 1983; 55(3):344-54. PubMed ID: 6191419
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on tissue culture plasminogen activator. II. The detection and assay of urokinase and plasminogen activator from LLC-PK cultures (porcine) by the synthetic substrate Nalpha-benzyloxycarbonyl-glycyl-glycyl-arginyl-4-methoxy-2-napthylamide.
    Huseby RM; Clavin SA; Smith RE; Hull RN; Smithwick EL
    Thromb Res; 1977 May; 10(5):679-87. PubMed ID: 882957
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasminogen activators: general aspects and recent developments].
    Reboud-Ravaux M
    Biochimie; 1985 Dec; 67(12):1197-216. PubMed ID: 3913465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
    Gurewich V
    Semin Thromb Hemost; 1989 Apr; 15(2):123-8. PubMed ID: 2501871
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary fibrin/fibrinogen derivatives.
    Hedner U
    Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in clinical fibrinolysis.
    Hessel LW; Kluft C
    Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.